Over the years working with Immundiagnostik, you may have seen our IDK® Extract product literature includes a lounging frog wearing sunglasses and asked yourself, “WTF? Why the frog?” You’re not alone. We at Immundiagnostik, Inc. have asked each...
With the prevalence of celiac disease and other gluten-related disorders on the rise, it is essential for patients to understand the importance of monitoring their diet and health to not only avoid damage to the small intestine, but also the development of more...
2 Minute Read Immundiagnostik’s IDKmonitor® Adalimumab Drug Level ELISA and Total ADA ELISA were recently featured in a publication by Plevris et al. Publication Summary A study at the Western General Hospital in Edinburgh, UK sought to discover the...
As the prevalence of celiac disease and other gluten-related intolerances continues to grow, people are beginning to realize that gluten can have a profound impact on their overall health. There is currently only one treatment for celiac disease which is a lifelong...
A quantitative test that detects gluten in stool samples is now available exclusively through Labcorp. MANCHESTER, NH, April 5, 2022 — Immundiagnostik, Inc., the North American subsidiary of Immundiagnostik AG, has collaborated with Labcorp (NYSE: LH), a leading...
2 Minute Read Immundiagnostik’s Calprotectin Mouse/Rat ELISA (S100A8/A9, MRP 8/14) was recently featured in a publication by Singh et al. Publication Summary Recent research has shown that 85% of all Parkinson’s disease patients experienced constipation years...
About the IDK® Vitamin D and IBD Testing Panel IBD and vitamin D deficiency are both highly prevalent health issues, particularly in the US and around the world. Studies have connected the two, showing that vitamin D deficiencies can lead to an increased risk of...
The connection between vitamin D levels and the presence of IBD has been well investigated. Several studies have found that individuals with vitamin D deficiency are at a greater risk of developing IBD. Further, in some studies, up to 60-70% of individuals with IBD...
